ライフサイエンスコーパス: nonpulmonary

1 egardless of whether the TB was pulmonary or nonpulmonary.

2 eceptor-driven apoptotic pathway in indirect/nonpulmonary ALI is virtually unstudied.

3 the Pa(O2)/FI(O2) ratio; (2) the presence of nonpulmonary and non-central nervous system (CNS) organ

4 s with direct ARDS than those with indirect (nonpulmonary) ARDS.

5 ho had died from pneumococcal pneumonia or a nonpulmonary cause was stained for MCs and tryptase.

6 D (n = 5) with lungs from infants dying from nonpulmonary causes (n = 5).

7 orticoids decrease PGI2 synthesis in certain nonpulmonary cell types.

8 Contrary to data reported for nonpulmonary DCs, expression of CCR6 was decreased on ma

9 nary disorders, and admission to the ICU for nonpulmonary diagnoses was associated with a more favora

10 Thirty-nine patients had 44 admissions for nonpulmonary diagnoses, including gastrointestinal disor

11 14 were placed on mechanical ventilation for nonpulmonary disorders (five died).

12 In contrast, mechanical ventilation for nonpulmonary disorders, and admission to the ICU for non

13 athogenesis of acute lung injury, shock, and nonpulmonary dysfunction is unclear.

14 Understanding the important effects of nonpulmonary factors (especially hemoglobin concentratio

15 2+]cyt than cells from patients with SPH and nonpulmonary hypertension disease.

16 nervous system dysfunction, acute associated nonpulmonary infection, neuromuscular blockade agents or

17 %) grade 3 or 4 adverse events were lung and nonpulmonary infections (13% and 11%, respectively).

18 n sepsis, this relationship was strongest in nonpulmonary infections.

19 have been reported in pulmonary, but not in nonpulmonary, LCH cases, suggesting organ-specific contr

20 Liver injury has been reported as a nonpulmonary manifestation of COVID-19, but characteriza

21 syndromes, platelets may also contribute to nonpulmonary manifestations and comorbidities of CF.

22 cted in adverse maternal outcomes, including nonpulmonary maternal outcomes, is not well characterize

23 indirect evidence that the hormone enhances nonpulmonary NO production in adults, estrogen may upreg

24 er the data cut; there was also one grade 4, nonpulmonary/non-CNS hemorrhage.

25 munoreactivity to distinguish pulmonary from nonpulmonary nonthyroid adenocarcinomas.

26 ct of the source of infection (pulmonary vs. nonpulmonary) on the development of acute respiratory di

27 developed fatal hypotension after developing nonpulmonary organ damage.

28 of chronic alcohol abuse on the incidence of nonpulmonary organ dysfunction also remained significant

29 ronic alcohol abuse on acute lung injury and nonpulmonary organ dysfunction are relatively unexplored

30 Patients with sepsis and acute nonpulmonary organ dysfunction at presentation were excl

31 tress syndrome and increases the severity of nonpulmonary organ dysfunction in patients with septic s

32 ory of chronic alcohol abuse had more severe nonpulmonary organ dysfunction when compared with nonalc

33 dollars vs. 5,785 dollars, p < 0.001), more nonpulmonary organ dysfunction, and higher hospital mort

34 ree-fold and was associated with more severe nonpulmonary organ dysfunction.

35 -derived classes, which were only related to nonpulmonary organ dysfunction.

36 /-10.4 with placebo, P=0.21) or days free of nonpulmonary organ failure (19.4+/-11.1 and 17.8+/-11.7,

37 ator-free days (p = 0.58), or development of nonpulmonary organ failure (p = 0.44).

38 Sepsis developed in 31% of patients, nonpulmonary organ failure in 20%, pneumothorax in 3%, a

39 outcomes included the number of days free of nonpulmonary organ failure to day 28, mortality at 28 da

40 Patients in the n-3 group also had fewer nonpulmonary organ failure-free days (12.3 vs 15.5; P =

41 acute respiratory distress syndrome and with nonpulmonary organ failures and tested for association o

42 ess syndrome severity and with the number of nonpulmonary organ failures at acute respiratory distres

43 cute respiratory distress syndrome severity, nonpulmonary organ failures, and worse outcomes in pedia

44 out comorbidities, severity of pulmonary and nonpulmonary organ failures, complications, respiratory

45 death, fewer ventilator-free days, and more nonpulmonary organ failures, even when only patients wit

46 had a median survival of 3 days with greater nonpulmonary organ injury, microbial growth, serum alani

47 g injury, and the patient had no significant nonpulmonary organ system dysfunction at randomization.

48 ry not due to sepsis and without evidence of nonpulmonary organ system dysfunction results in short-t

49 jury score (LIS) and etiology, and preceding nonpulmonary organ-system dysfunction (OSD) on the outco

50 lation and intensive care without increasing nonpulmonary-organ failures.

51 ase of most metabolites, suggesting probable nonpulmonary origin (except for serotonin, interaction P

52 The intensive care unit length of stay in nonpulmonary patients and improvement in intensive care

53 he clinical risk factors as pulmonary versus nonpulmonary predisposing conditions and infection-relat

54 a coagulopathy; the other five patients had nonpulmonary primary tumors.

55 Main risk factors were pneumonia (35.3%) and nonpulmonary sepsis (31.5%).

56 In patients with nonpulmonary sepsis as the primary acute respiratory dis

57 t organ dysfunction in trauma patients, with nonpulmonary sepsis being the most common cause of indir

58 sk of acute respiratory distress syndrome in nonpulmonary sepsis was restricted to patients with 4-(m

59 spiratory distress syndrome in patients with nonpulmonary sepsis.

60 veloping ARDS in patients with pulmonary and nonpulmonary sepsis.

61 syndrome (ARDS) in trauma, transfusion, and nonpulmonary sepsis.

62 siological significance of Fas activation in nonpulmonary/shock-induced ALI and the feasibility of in

63 of pulmonary biopsy, results of biopsies of nonpulmonary sites and of immunoelectrophoresis, and oth

64 ENTM cases required NTM isolation from a nonpulmonary specimen, excluding stool and rectal swabs.

65 accuracy of assays (especially when testing nonpulmonary specimens), and the interpretation of resul

66 ) and from patients intubated electively for nonpulmonary surgery (n = 14).

67 Whether macrophage development in nonpulmonary tissues is similarly dependent on GM-CSF is

68 The treatment of nonpulmonary tuberculosis followed the same plan, but wh

69 tion and estrogen enhances PGI2 synthesis in nonpulmonary vascular cells.

70 ) was associated with low atrial voltage and nonpulmonary vein ectopies.

71 vena cava (SVC) is one of the most important nonpulmonary vein origins of atrial fibrillation, and SV

72 Ablation of nonpulmonary vein sites is increasingly being recognized

73 all animals (100%) with lesion durability at nonpulmonary vein sites proven in most (98%).

74 ity mapping system safely guided ablation of nonpulmonary vein targets in persistent AF patients with

75 Background Identification and elimination of nonpulmonary vein targets may improve clinical outcomes

76 dergoing antral pulmonary vein isolation and nonpulmonary vein trigger ablation and correlated recurr

77 d with standard pulmonary vein isolation and nonpulmonary vein trigger ablation in patients undergoin

78 ndard ablation (pulmonary vein isolation and nonpulmonary vein trigger ablation) versus (2) standard

79 women, compared with men, tend to have more nonpulmonary vein triggers and advanced atrial disease.

80 um and posterior wall isolation, ablation of nonpulmonary vein triggers disclosed by high dosage of i

81 ion targeting pulmonary veins and documented nonpulmonary vein triggers improves the maintenance of s

82 The location of the nonpulmonary vein triggers includes the coronary sinus,

83 Women were less likely to have ancillary (nonpulmonary vein) ablation procedures performed during

84 seminomatous histology (.002), metastases to nonpulmonary visceral sites (bone, liver, and brain; .00